CARCINOMA OF THE CORPUS UTERI.

No abstract is available for this paper.

• Publication year

  1964

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1964-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(64)90250-9PMID 14104777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carcinoma of the Endometrium: An Evaluation of Preoperative Radiation Therapy

  1961cited by this paper
• Treatment of endometrial adenocarcinoma; a study of 381 cases at the New York Hospital; a preliminary report.

  1956cited by this paper
• Treatment of endometrial adenocarcinoma; a study of 381 cases at the New York Hospital; a preliminary report.

  1956cited by this paper
• THE PLACE OF RADIATION THERAPY AND OF SURGERY IN THE TREATMENT OF UTERINE CANCER

  1955cited by this paper
• The rationale for radical panhysterectomy and pelvic node excision in carcinoma of the corpus uteri; clinical and pathological data on the mode of spread of endometrial carcinoma.

  1954cited by this paper
• Carcinoma of the corpus; its classification and treatment.

  1954cited by this paper
• VAGINAL RECURRENCES IN CARCINOMA OF THE BODY OF THE UTERUS AND THEIR PREVENTION BY RADIUM THERAPY

  1953cited by this paper
• Observations on the surgical pathology, selective lymphadenectomy, and classification of endometrial adenocarcinoma

  1952cited by this paper

• Is it safe to preserve uterus after live birth following progestin-based fertility-sparing treatment for endometrial cancer or atypical hyperplasia: A long-term retrospective cohort study.

  2026cites this paper
• Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mapping.

  2025cites this paper
• Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.

  2025cites this paper
• The past, present, and future of FIGO staging of endometrial cancer

  2025cites this paper
• Is presumed clinical stage I endometrial cancer using PET-CT and MRI accurate in predicting surgical staging?

  2025cites this paper
• Robot-Assisted Surgery for Endometrial Cancer Using KangDuo versus Da Vinci Systems: A Retrospective Comparative Study

  2025cites this paper
• Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study

  2024cites this paper
• The Role of Endometrial Sampling before Hysterectomy in Premenopausal Women with Abnormal Uterine Bleeding

  2024cites this paper
• Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria

  2024cites this paper
• Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

  2024cites this paper
• Association Between Lymphovascular Space Invasion and Preoperative CA-125 Antigen and Fibrinogen in Patients with Endometrial Carcinoma

  2024cites this paper
• Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe

  2024cites this paper
• Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe

  2024cites this paper
• ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

  2024cites this paper
• Endometrioid Carcinoma Four Years After Hysterectomy: A Rare Case Report

  2024cites this paper
• The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma

  2023cites this paper
• CLINICO-EPIDEMIOLOGICAL FEATURES OF PATIENTS WITH ENDOMETRIAL CARCINOMA IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAMS UNIVERSITY HOSPITALS IN EGYPT

  2023cites this paper
• Prognostic Importance of Lymph-Vascular Space Involvement in Stage I Endometrioid Type Endometrial Cancer

  2023cites this paper
• Effect of lymph node sampling type on oncologic outcomes in endometrial cancers: comprehensive pelvic and paraaortic lymphadenectomy vs. sentinel lymph node mapping with indocyanine green.

  2023cites this paper
• Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

  2023cites this paper
• Ultrasonography, macroscopy, and frozen section: whıch is better for predicting deep myometrial invasıon in endometrial cancer?

  2023cites this paper
• A Reappraisal of Lymphadenectomy in Common Gynecological Cancers

  2023cites this paper
• Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study

  2023cites this paper
• Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis

  2023cites this paper
• An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer

  2023cites this paper
• Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines

  2023cites this paper
• The Relationship Between Leptin Receptor Expression and Endometrial Carcinoma; A Case-Control Study

  2023cites this paper
• Late distant recurrence of endometrial cancer in the lung after 5 years of radical surgery: a case report

  2023cites this paper
• The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis

  2022cites this paper
• Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis

  2022influential citation
• Hybrid PET/MRI in Staging Endometrial Cancer

  2022cites this paper
• Survival for endometrial cancer as a second primary malignancy

  2022cites this paper
• Diagnostic accuracy of hysteroscopy vs dilation and curettage (D&C) for atypical endometrial hyperplasia in patients performing hysterectomy or serial follow-up

  2022cites this paper
• Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes

  2022cites this paper
• Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes

  2022cites this paper
• Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review

  2022cites this paper
• The accuracy and clinical impact of intraoperative frozen section in determining the extent of surgical intervention in patients with early stage endometrial cancer

  2022cites this paper
• Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A Comutations

  2022cites this paper
• BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity

  2022cites this paper
• Current Approaches to the Management of Patients with Endometrial Cancer

  2022cites this paper
• Isolated precaval adenopathy after surgically treated endometrial cancer

  2022cites this paper
• Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer

  2022cites this paper
• Expression of the Hippo Pathway Core Components in Endometrial Cancer and Its Association with Clinicopathologic Features

  2022cites this paper
• A Rare Presentation of Endometrial Cancer recurrence with Scapular metastasis: A Case Report and Review of the Literature

  2022cites this paper
• Importance of p53, bcl-2 genes in uterine body cancer and their role in prediction

  2022cites this paper
• Trend of uterine cancer at Hiwa Cancer Hospital of the Sulaymaniyah Province of Iraqi Kurdistan over a five-year period

  2022cites this paper
• Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States

  2022cites this paper
• Vibrational Biospectroscopy: An Alternative Approach to Endometrial Cancer Diagnosis and Screening

  2022cites this paper
• Components of NOTCH Signaling for Uterine Cancer Patients' Prognosis

  2022cites this paper
• Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer

  2022cites this paper
• HISTOPATHOLOGIC PARAMETERS OF POSITIVE LYMPH NODE PREDICTABILITY IN ENDOMETRIAL CANCER

  2022cites this paper
• Does Preoperative Diagnosis Will Change the Treatment Plan of Clear Cell Carcinoma of Endometrium Masquerading as Desmoid Tumor of Anterior Abdominal Wall?: a Case Report

  2021cites this paper
• Expression of BCL-2 and KI-67 in Cyclical Endometrium and in Endometrial Hyperplasia

  2021cites this paper
• The current evidence for the use of minimally-invasive surgery in endometrial cancer

  2021cites this paper
• 72. Comparison of Survival Outcomes of Lymphovascular_Layout 1

  2021cites this paper
• Targeting Wnt Signaling in Endometrial Cancer

  2021cites this paper
• Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?

  2021cites this paper
• The prognostic value of squamous differentiation in endometrioid type endometrial cancer: a matched analysis

  2021cites this paper
• Patterns of Myometrial Invasion in Endometrial Adenocarcinoma with Emphasizing on Microcystic, Elongated and Fragmented (MELF) Glands Pattern: A Narrative Review of the Literature

  2021cites this paper
• Initial surgical management of bulky malignant type II tumors of the endometrium by a robotic approach

  2021cites this paper
• The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women

  2021cites this paper
• A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression

  2021cites this paper
• Computer-Aided Segmentation and Machine Learning of Integrated Clinical and Diffusion-Weighted Imaging Parameters for Predicting Lymph Node Metastasis in Endometrial Cancer

  2021cites this paper
• Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

  2021cites this paper
• Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol

  2021cites this paper
• Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma

  2021cites this paper
• Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer

  2021cites this paper
• The Perspectives of Fertility Preservation in Women with Endometrial Cancer

  2021cites this paper
• Detection of bone metastases in uterine cancer: How common are they and should PET/CT be the standard for diagnosis?

  2021cites this paper
• Surgical Treatment and Fertility Perservation in Endometrial Cancer

  2021cites this paper
• Lung metastasis of gynecologic cancers

  2021cites this paper
• Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence

  2021cites this paper
• Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort

  2021cites this paper
• Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?

  2021cites this paper
• PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review

  2021cites this paper
• A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma

  2021cites this paper
• Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma

  2021cites this paper
• Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis

  2021cites this paper
• Evaluation of the Safety of Ovarian Preservation at Early Stage of Endometrial Cancer in Premenopausal Women

  2021cites this paper
• Evaluation of clinical outcome of laparoscopic hysterectomy versus open abdominal hysterectomy with pelvic lymphadenectomy in endometrial carcinoma early stage

  2021cites this paper
• Validation of an Endometrial Tumor Diameter Model for Risk Assessment in the Absence of Lymph Node Mapping.

  2020cites this paper
• Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus

  2020cites this paper
• Lymph node evaluation in endometrial cancer: how did it change over the last two decades?

  2020cites this paper
• Is there a difference between synchronous multiple primary cancer and metastasis cancer?

  2020cites this paper
• Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers

  2020cites this paper
• Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours

  2020cites this paper
• Recent Advances in Endometrial Cancer

  2020cites this paper
• Die Rolle der Lymphonodektomie beim Endometriumkarzinom

  2020influential citation
• Lymphatic involvement in endometrial cancer—an overview of embryological, anatomical and technical aspects

  2020cites this paper
• RADIATION THERAPY IN MANAGEMENT OF ENDOMETRIAL CARCINOMA: THE RESULTS OF A SINGLE INSTITUTION

  2020influential citation
• Evaluation of Surgical Lymphadenectomy in Management of Cancer Endometrial

  2020cites this paper
• High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)

  2020cites this paper
• UTERİN SERÖZ KARSİNOM VE UTERİN BERRAK HÜCRELİ KARSİNOM TANISI ALAN HASTALARDA KLİNİKOPATOLOJİK ÖZELLİKLERİN VE SAĞ KALIM SONUÇLARININ KARŞILAŞTIRILMASI Comparison Of Clinicopathologic Characteristics And Survivals In Patients With Uterine Serous And Clear Cell Carcinoma

  2020cites this paper
• The value of new sonographic modalities, demographic, biometric and proliferative variables for the risk prediction in endometrial cancer

  2020cites this paper
• Corded and hyalinized endometrioid carcinoma: a rare case and review of the literature

  2020cites this paper
• Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.

  2020cites this paper
• Ultrasound assessment and risk prediction in women with endometrial cancer

  2020cites this paper
• A nomogram prediction model for lymph node metastasis in endometrial cancer patients

  2020cites this paper
• Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms.

  2020cites this paper